Medicare Enrolled
Dr. Shelby Morrisroe, M.D.
Urology Physician · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Morrisroe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morrisroe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Morrisroe
Dr. Shelby Morrisroe is an urology physician in Torrance, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Morrisroe performed 17,944 Medicare services across 5,304 unique beneficiaries.
Between the years covered by Open Payments, Dr. Morrisroe received a total of $10,176 from 71 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Morrisroe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 8% volume in CA
$10,176 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,944
Medicare services
Top 8% in CA for urology physician
5,304
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
8,100 | $5 | $20 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,442 | $2 | $9 |
| BCG treatment for bladder cancer | 1,122 | $2 | $10 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
901 | $52 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
807 | $95 | $600 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
777 | $9 | $60 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
769 | $40 | $240 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
581 | $103 | $605 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
499 | $94 | $560 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
451 | $61 | $340 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
351 | $40 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
340 | $69 | $440 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
198 | $126 | $780 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
185 | $51 | $170 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
161 | $208 | $1,230 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
161 | $114 | $640 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
133 | $18 | $120 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
81 | $50 | $440 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
71 | $338 | $1,951 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
67 | $340 | $1,975 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
67 | $7 | $70 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
67 | $28 | $310 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
67 | $178 | $1,010 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 64 | $134 | $720 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
61 | $71 | $430 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
54 | $10 | $190 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
47 | $12 | $80 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
41 | $80 | $600 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
37 | $54 | $310 |
| New patient office visit, complex (60-74 min) | 35 | $162 | $1,020 |
| Insertion of temporary bladder tube | 26 | $36 | $215 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
24 | $86 | $535 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $120 | $840 |
| Injection of implant material into bladder or urethra A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope. |
23 | $165 | $640 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $29 | $180 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
21 | $20 | $400 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $78 | $540 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $109 | $566 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $253 | $1,585 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
11 | $44 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
53.3% medium
46.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,176
Total received (2018-2024)
Avg $1,454/year across 7 years
Top 20% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,994 (88.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$571 (5.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$457 (4.5%)
Scientific / Research
Research funding and grants
$154 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,297
2023
$2,627
2022
$2,423
2021
$926
2020
$557
2019
$943
2018
$1,403
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$361
Axonics, Inc.
$181
Sumitomo Pharma America, Inc.
$166
Teleflex LLC
$62
Laborie Medical Technologies Corp.
$53
Valencia Technologies Corporation
$52
BIOTISSUE HOLDINGS INC.
$50
Tolmar, Inc.
$46
Merck Sharp & Dohme LLC
$45
UROGEN PHARMA, INC.
$34
Pacira Pharmaceuticals Incorporated
$33
BLUEWIND MEDICAL
$29
PFIZER INC.
$26
Janssen Biotech, Inc.
$25
Telix Pharmaceuticals
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
Astellas Pharma US Inc
$21
PROGENICS PHARMACEUTICALS, INC.
$19
Ethicon US, LLC
$19
MILLICENT US INC
$15
COLOPLAST CORP
$13
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
SN Holdings, LLC
$1,588
Astellas Pharma US Inc
$1,361
Axonics, Inc.
$1,054
ABBVIE INC.
$905
Medtronic USA, Inc.
$724
Janssen Biotech, Inc.
$275
Sumitomo Pharma America, Inc.
$264
BIOTISSUE HOLDINGS, INC.
$195
PFIZER INC.
$192
Dendreon Pharmaceuticals LLC
$188
Teleflex LLC
$188
TISSUETECH, INC.
$151
Boston Scientific Corporation
$146
Medtronic, Inc.
$142
Merck Sharp & Dohme LLC
$132
Bayer HealthCare Pharmaceuticals Inc.
$124
AbbVie, Inc.
$117
Acerus Pharmaceuticals Corporation
$116
Progenics Pharmaceuticals, Inc.
$112
Allergan, Inc.
$109
Blue Earth Diagnostics Limited
$108
PROCEPT BioRobotics Corporation
$96
UROVANT SCIENCES INC
$93
Allergan Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$90
TOLMAR Pharmaceuticals, Inc.
$66
Duchesnay USA Incorporated
$65
Myriad Genetic Laboratories, Inc.
$63
Endo Pharmaceuticals Inc.
$56
Myovant Sciences Inc.
$56
Metuchen Pharmaceuticals
$55
Laborie Medical Technologies Corp.
$53
Valencia Technologies Corporation
$52
UroGen Pharma, Inc.
$51
BIOTISSUE HOLDINGS INC.
$50
BioTissue Holdings, Inc.
$48
COLOPLAST CORP
$48
Otsuka America Pharmaceutical, Inc.
$47
Antares Pharma, Inc.
$46
Tolmar, Inc.
$46
NeoTract Inc.
$45
BAXTER HEALTHCARE
$41
Avadel Specialty Pharmaceuticals, LLC
$40
ConvaTec Inc.
$38
Osiris Therapeutics Inc.
$37
TherapeuticsMD, Inc.
$35
UROGEN PHARMA, INC.
$34
Pacira Pharmaceuticals Incorporated
$33
Ferring Pharmaceuticals Inc.
$32
Coloplast Corp
$32
AstraZeneca Pharmaceuticals LP
$30
Hollister Incorporated
$30
BLUEWIND MEDICAL
$29
Agiliti Surgical, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Amgen Inc.
$27
Telix Pharmaceuticals
$24
Amniox Medical, Inc.
$24
CONMED Corporation
$22
Cook Incorporated
$21
Merck Sharp & Dohme Corporation
$20
PROGENICS PHARMACEUTICALS, INC.
$19
Sun Pharmaceutical Industries Inc.
$19
Ethicon US, LLC
$19
Smith+Nephew, Inc.
$18
Axonics Modulation Technologies, Inc.
$16
AKRIMAX PHARMACEUTICALS, LLC
$16
MILLICENT US INC
$15
Mission Pharmacal Company
$14
ACCORD HEALTHCARE, INC.
$13
Photocure Inc
$13
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
AIRSEAL · AVEED · Altis · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIJUVA · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · CAMCEVI · CAPIO · CLARIX · COOK MEDICAL WIRE GUIDES · Cysview · ELIGARD · ERLEADA · Echelon; Endopath · Eclipse · Erleada · Exparel · FEMRING · FIRMAGON · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL BPH · GENTLECATH · GRAFIX/GRAFIXPL/STRAVIX · ILLUCCIX · IMVEXXY · INTERSTIM · INTERSTIM ICON · Infyna Chic · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · Osphena · Otrexup · PREMARIN · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · SOLESTA · SPEEDICATH · STRAVIX · SUTENT · Saffron · Solyx SIS System · Stendra · TOVIAZ · UROLIFT · Uribel · UroLift · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · YONSA · eCoin Device Kit · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
352
Per 100K population
3.6
County median income
$87,760
Nearest hospital
PROVIDENCE LITTLE COMPANY OF MARY MED CTR TORRANCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Morrisroe is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Morrisroe experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Morrisroe performed 8,100 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morrisroe receive payments from pharmaceutical companies?
Yes. Dr. Morrisroe received a total of $10,176 from 71 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morrisroe's costs compare to other urology physicians in Torrance?
Dr. Morrisroe's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morrisroe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Torrance
Browse urology physicians in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
SN Holdings, LLC Payments to Doctors
See all physicians who received payments from SN Holdings, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology